Jun 272018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, TX – Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery technologies, today announced that Jerrry McLaughlin has been appointed as Chief Executive Officer of Neos, effective today, June 27, 2018.… => Read full post

Neos Therapeutics appoints Jerry McLaughlin to its Board of Directors as CEO

From:: Neos Therapeutics appoints Jerry McLaughlin to its Board of Directors as CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: